Re-evaluation of central America drug market where to start?
Contribuinte(s) |
Alves, Sara |
---|---|
Data(s) |
25/05/2016
29/01/2017
01/01/2016
|
Resumo |
Atral is a Portuguese Pharmaceutical firm devoted to the production of finished drugs. Due to domestic market hurdles, Atral is now, more than ever, focused in the world. The Central America region seams alluring due to its context alignment with firm’s resources bundle. As Atral should approach one regional country at a time, the purpose of this thesis is to find out the most suitable country to approach now. Hence a tailored scoring model was applied, based on contexts analysis and importance of benchmarking indicators to both firm and industry. Upon analysis of the highest scored country, the most appropriate entry modes were assessed. |
Identificador |
http://hdl.handle.net/10362/17580 201530856 |
Idioma(s) |
eng |
Direitos |
embargoedAccess |
Palavras-Chave | #Central America #Internationalization #Pharmaceutical industry #Panama #Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
Tipo |
masterThesis |